MedTrace Logo

Use of Ketorolac in Management of Post-Operative Pain After Heart Surgery

NCT00161577 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2009-05-13

No results posted yet for this study

Summary

This study evaluates the safety and efficacy of ketorolac for post-operative pain management after heart surgery. Ketorolac appears to provide enhanced pain relief while also decreasing the requirements for morphine during the (immediate) 24-hour post-operative period.

Conditions

  • Pain Management Following Cardiopulmonary Bypass Surgery

Interventions

DRUG

Ketorolac

Intravenous ketorolac every 6 hours for 24 hours

OTHER

Placebo

Placebo Comparator

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Gergory Kerr, M.D., MBA · Weill Medical College of Cornell University, New York Presbyterian Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2006-06-30
Completion
2006-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00161577 on ClinicalTrials.gov